These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

681 related articles for article (PubMed ID: 33144503)

  • 1. Curtailing FGF19's mitogenicity by suppressing its receptor dimerization ability.
    Niu J; Zhao J; Wu J; Qiao G; Gu J; Zhou C; Li Q; Ying L; Wang D; Lin H; Li X; Mohammadi M; Huang Z
    Proc Natl Acad Sci U S A; 2020 Nov; 117(46):29025-29034. PubMed ID: 33144503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective activation of FGFR4 by an FGF19 variant does not improve glucose metabolism in ob/ob mice.
    Wu X; Ge H; Lemon B; Weiszmann J; Gupte J; Hawkins N; Li X; Tang J; Lindberg R; Li Y
    Proc Natl Acad Sci U S A; 2009 Aug; 106(34):14379-84. PubMed ID: 19706524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mouse species-specific control of hepatocarcinogenesis and metabolism by FGF19/FGF15.
    Zhou M; Luo J; Chen M; Yang H; Learned RM; DePaoli AM; Tian H; Ling L
    J Hepatol; 2017 Jun; 66(6):1182-1192. PubMed ID: 28189755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FGF19 regulates cell proliferation, glucose and bile acid metabolism via FGFR4-dependent and independent pathways.
    Wu AL; Coulter S; Liddle C; Wong A; Eastham-Anderson J; French DM; Peterson AS; Sonoda J
    PLoS One; 2011 Mar; 6(3):e17868. PubMed ID: 21437243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fundamentals of FGF19 & FGF21 action in vitro and in vivo.
    Adams AC; Coskun T; Rovira AR; Schneider MA; Raches DW; Micanovic R; Bina HA; Dunbar JD; Kharitonenkov A
    PLoS One; 2012; 7(5):e38438. PubMed ID: 22675463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic utilities of fibroblast growth factor 19.
    Wu X; Li Y
    Expert Opin Ther Targets; 2011 Nov; 15(11):1307-16. PubMed ID: 21961833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of fibroblast growth factor 19 in the control of glucose homeostasis.
    Schaap FG
    Curr Opin Clin Nutr Metab Care; 2012 Jul; 15(4):386-91. PubMed ID: 22617565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The anti-obesity effect of FGF19 does not require UCP1-dependent thermogenesis.
    Antonellis PJ; Droz BA; Cosgrove R; O'Farrell LS; Coskun T; Perfield JW; Bauer S; Wade M; Chouinard TE; Brozinick JT; Adams AC; Samms RJ
    Mol Metab; 2019 Dec; 30():131-139. PubMed ID: 31767164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Making way for suppressing the FGF19/FGFR4 axis in cancer.
    Prieto-Dominguez N; Shull AY; Teng Y
    Future Med Chem; 2018 Oct; 10(20):2457-2470. PubMed ID: 30325210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular elements in FGF19 and FGF21 defining KLB/FGFR activity and specificity.
    Agrawal A; Parlee S; Perez-Tilve D; Li P; Pan J; Mroz PA; Kruse Hansen AM; Andersen B; Finan B; Kharitonenkov A; DiMarchi RD
    Mol Metab; 2018 Jul; 13():45-55. PubMed ID: 29789271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of FGF19 induced FGFR4 activation in the regulation of glucose homeostasis.
    Wu X; Li Y
    Aging (Albany NY); 2009 Dec; 1(12):1023-7. PubMed ID: 20157585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibroblast growth factor 15/19 (FGF15/19) protects from diet-induced hepatic steatosis: development of an FGF19-based chimeric molecule to promote fatty liver regeneration.
    Alvarez-Sola G; Uriarte I; Latasa MU; Fernandez-Barrena MG; Urtasun R; Elizalde M; Barcena-Varela M; Jiménez M; Chang HC; Barbero R; Catalán V; Rodríguez A; Frühbeck G; Gallego-Escuredo JM; Gavaldà-Navarro A; Villarroya F; Rodriguez-Ortigosa CM; Corrales FJ; Prieto J; Berraondo P; Berasain C; Avila MA
    Gut; 2017 Oct; 66(10):1818-1828. PubMed ID: 28119353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Engineered FGF19
    Shi L; Zhao T; Huang L; Pan X; Wu T; Feng X; Chen T; Wu J; Niu J
    BMC Biotechnol; 2023 Oct; 23(1):43. PubMed ID: 37789318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential receptor selectivity of the FGF15/FGF19 orthologues determines distinct metabolic activities in
    Hansen AMK; Vienberg SG; Lykkegaard K; Zhao X; Tingqing G; Han D; Zhang X; Thøgersen H; Sass-Ørum K; Tagmose T; Raun K; Andersen B
    Biochem J; 2018 Sep; 475(18):2985-2996. PubMed ID: 30127091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Understanding the structure-function relationship between FGF19 and its mitogenic and metabolic activities.
    Wu X; Li Y
    Adv Exp Med Biol; 2012; 728():195-213. PubMed ID: 22396171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Separating Tumorigenicity from Bile Acid Regulatory Activity for Endocrine Hormone FGF19.
    Zhou M; Wang X; Phung V; Lindhout DA; Mondal K; Hsu JY; Yang H; Humphrey M; Ding X; Arora T; Learned RM; DePaoli AM; Tian H; Ling L
    Cancer Res; 2014 Jun; 74(12):3306-16. PubMed ID: 24728076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Enterokine Fibroblast Growth Factor 15/19 in Bile Acid Metabolism.
    Cariello M; Piglionica M; Gadaleta RM; Moschetta A
    Handb Exp Pharmacol; 2019; 256():73-93. PubMed ID: 31123830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel Abs targeting the N-terminus of fibroblast growth factor 19 inhibit hepatocellular carcinoma growth without bile-acid-related side-effects.
    Liu H; Zheng S; Hou X; Liu X; Du K; Lv X; Li Y; Yang F; Li W; Sui J
    Cancer Sci; 2020 May; 111(5):1750-1760. PubMed ID: 32061104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A gut-brain axis regulating glucose metabolism mediated by bile acids and competitive fibroblast growth factor actions at the hypothalamus.
    Liu S; Marcelin G; Blouet C; Jeong JH; Jo YH; Schwartz GJ; Chua S
    Mol Metab; 2018 Feb; 8():37-50. PubMed ID: 29290621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A nontumorigenic variant of FGF19 treats cholestatic liver diseases.
    Luo J; Ko B; Elliott M; Zhou M; Lindhout DA; Phung V; To C; Learned RM; Tian H; DePaoli AM; Ling L
    Sci Transl Med; 2014 Jul; 6(247):247ra100. PubMed ID: 25080475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.